Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::
:::

期刊發表

【2023年期刊發表】(本科醫師為第一作者或通訊作者之文章)

  1. Chuang C, Lee KC, Wang YP, Lee PC, Chang TE, Huang YH, Lin YT*, Hou MC. High carriage rate of extended-spectrum β-lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation. Eur J Clin Microbiol Infect Dis 2023;42(9):1103-1113. (IF:4.5)
  2. Huang SF, Wu AYJ, Lee SSJ, Huang YS, Lee CY, Yang TL, Wang HW, Chen HJ, Chen YC, Ho TS, Kuo CF, Lin YT*. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis. J Microbiol Immunol Infect 2023;56(3):442-454. (IF:7.4)
  3. Lin YT*, Chuang C, Chou SH, Juan CH, Yang TC, Kreiswirth BN, Chen L. Emergence of OXA-48-producing hypervirulent Klebsiella pneumoniae strains in Taiwan. Eur J Clin Microbiol Infect Dis 2023;7-Dec:doi: 10.1007/s10096-023-04733-3. (IF:4.5)

 

【2022年期刊發表】(本科醫師為第一作者或通訊作者之文章)

  1. Chen IR, Lin SN, Wu XN, Chou SH, Wang FD, Lin YT*. Clinical and Microbiological Characteristics of Bacteremic Pneumonia Caused by Klebsiella pneumoniae. Front Cell Infect Microbiol. 2022 Jun 23;12:903682. (2021 IF: 6.073)

  2. Huang PH, Chen WY, Chou SH, Wang FD, Lin YT*. Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections. Microbiol Spectr. 2022 Jun 29;10(3):e0038122. (2021 IF: 9.043)

  3. Huang SF*, Huang YC, Lee CT, Chou KT, Chen HP, Huang CC, Ji DD, Chan YJ, Yang YY. Cytomegalovirus viral interleukin-10 in patients with Aspergillus infection and effects on clinical outcome. Mycoses. 2022 Jul;65(7):760-769. (2021 IF: 4.931)

  4. Juan CH, Chou SH, Chen IR, Yang CI, Lin YT*, Chen L. Intestinal colonisation with hypervirulent or third-generation cephalosporin-resistant Klebsiella pneumoniae strains upon hospital admission in a general ward in Taiwan. Int J Antimicrob Agents. 2022 Aug;60(2):106624. (2021 IF: 15.441)

 

【2021年期刊發表】(本科醫師為第一作者或通訊作者之文章)

  1. Chen AP, Chu IY, Yeh ML, Chen YY, Lee CL, Lin HH, Chan YJ, Chen HP*. Differentiating impacts of non-pharmaceutical interventions on non-coronavirus disease-2019 respiratory viral infections: Hospital-based retrospective observational study in Taiwan. Influenza Other Respir Viruses 2021;15:478-87. (IF:4.380)
     
  2. Chen AP, Chuang C, Huang YC, Wu PF, Huang SF, Cheng NC, Lin YT, Chen SJ, Huang LJ, Lee CL, Chen HP*, Chan YJ, Wang FD. The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak. J Microbiol Immunol Infect 2021;54:801-7. (IF:4.399)
     
  3. Chen IR, Huang PH, Wu PF, Wang FD, Lin YT*. Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenem-resistant Klebsiella pneumoniae. J Glob Antimicrob Resist 2021; 25:326-30. (IF:4.035)
     
  4. Chen LY, Hwang AC, Huang CY, Chen LK, Wang FD, Chan YJ*. CMV infection, CD19(+) B cell depletion, and Lymphopenia as predictors for unexpected admission in the institutionalized elderly. Immun Ageing 2021; 18(1):-. (IF:6.400)
     
  5. Chen PL, Hsiao YH, Chuang C, Feng JY, Ho HL, Lin YT, Chen SJ, Huang SF, Chen HP, Chou TY, Chen YM*, Wang FD*. The clinical manifestations and interval changes of reverse-transcriptase quantitative polymerase chain reactions among different specimens of coronavirus disease 2019 patients. J Chin Med Assoc 2021;84:151-7. (IF:2.743)
     
  6. Cheng YH, Chou SH, Huang PH, Yang TC, Juan YF, Kreiswirth BN, Lin YT*, Chen L. Characterization of a mcr-1 and CRISPR-Cas System Co-harboring Plasmid in a Carbapenemase-Producing High-Risk ST11 Klebsiella pneumoniae Strain. Front Microbiol 2021;12:762947. (IF:5.640)
     
  7. Feng JY, Lee YT, Pan SW, Yang KY, Chen YM, Yen D, Li SY, Wang FD*. Comparison of colistin-induced nephrotoxicity between two different formulations of colistin in critically ill patients: a retrospective cohort study. Antimicrob Resist Infect Control 2021; 10:111. (IF:4.887)
     
  8. Huang PH, Cheng YH, Chen WY, Juan CH, Chou SH, Wang JT, Chuang C, Wang FD, Lin YT*. Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae. Int J Antimicrob Agents 2021; 57:106342. (IF:5.283)
     
  9. Huang SF*, Huang CC, Chou KT, Chan YJ, Yang YY, Wang FD. Chronic Pulmonary Aspergillosis: Disease Severity Using Image Analysis and Correlation with Systemic Proinflammation and Predictors of Clinical Outcome. J Fungi 2021;7:842. (IF:5.816)
     
  10. Lu W, Chen HP*, Chan YJ, Wang FD. Clinical significance of post-treatment viral load of cytomegalovirus in patients with hematologic malignancies. J Microbiol Immunol Infect 2021; 54(2):245-252. (IF:4.399)
     
  11. Tai CC, Tsai CH, Huang YH, Lee CL, Chen HP*, Chan YJ*. Detection of respiratory viruses in adults with respiratory tract infection using a multiplex PCR assay at a tertiary center. J Microbiol Immunol Infect 2021; 54(5):858-864. (IF:4.399)
     
  12. Hsu CH, Chen HP*, Chen PL, Chan YJ. Detection of influenza and non-influenza respiratory viruses in lower respiratory tract specimens among hospitalized adult patients and analysis of the clinical outcome. J Microbiol Immunol Infect. 2021 Dec 14:S1684-1182(21)00268-1. (2021 IF: 10.273)
     

* 為通訊作者

最後更新:

回到最上